The ITGB3 protein, known as the integrin beta chain beta 3, was identified as an epithelial-to-mesenchymal transition biomarker in colorectal cancer, prostate cancer, and breast cancer [31, 32]. This evidence concerns the gene ITGB3 and breast cancer.